So this just happened………
Slope of Hope Blog Posts
Slope initially began as a blog, so this is where most of the website’s content resides. Here we have tens of thousands of posts dating back over a decade. These are listed in reverse chronological order. Click on any category icon below to see posts tagged with that particular subject, or click on a word in the category cloud on the right side of the screen for more specific choices.
Momentum Stocks Moving on Earnings
Preface from Tim: one “bullish breakout” I really like is SlopeCharts usage (shown below), which has been steadily climbing since we launched the new site last weekend. Please note clicking on any of the hyperlinks in this post will bring up its chart, and also remember that preceding a ticker symbol with a “$” in the comments section (example: $FB) will provide a hyperlink in the same manner.
Here are five momentum stocks making a move primarily on earnings.
Arrowhead Pharmaceuticals, Inc. (ARWR) jumped $1.25 to $9.00 on 5.6 million shares Wednesday, almost four times its average volume. The drug developer reported fiscal second quarter earnings on Tuesday that matched Wall Street expectations. The move broke the stock out of a two-month coiling consolidation. At its intraday high of $9.60, the stock got up to resistance at the rising trendline before backing off. A breakthrough there could lead to $13.
Facebook’s Full Recovery
It’s quite evident the Facebook privacy scandal, which garnered worldwide attention and lengthy Congressional hearings, is now a minuscule footnote in history. Nobody cares.
Long Tweets?
OK, no spin, no joking, no kidding: this is the first morning since the launch that life (and the site) hasn’t sucked. I am far too superstitious to even type such a thing without trepidation, but we were on a huge roll last night, and I knew we had some great breakthroughs. So Slope “feels”right to me again,and we’re focusing on building and improving instead of preventing nuclear bombs going off.
Anyway.
I’m going to shock you by not only making a long suggestion, but making it on a crap stock. This occurred to me because I was quite surprised to see how well Splunk (SPLK) recovered from its own terrible post-IPO outing. Pay particular attention to that base and breakout (horizontal).
